Target intelligence / Profile preview

Tumor Cell Membrane Antigen (via Natural Killer Cell Recognition)

Molecular classification
Receptor Ligand, Cell Surface Antigen
01

Overview

Tumor cell membrane antigens recognized by natural killer (NK) cells are a diverse set of stress-induced or altered self-molecules expressed on the surface of transformed cells. These antigens serve as ligands for activating and inhibitory receptors on NK cells, dictating the balance between NK cell activation and tolerance towards tumor cells. Key examples include NKG2D ligands (MICA/B, ULBPs), NCR ligands (NKp30, NKp44, NKp46 ligands), and downregulation/loss of HLA class I molecules. Therapeutic strategies aim to enhance ligand expression for activating receptors or block inhibitory pathways, boosting anti-tumor NK cell activity.

Other names
NKG2D ligandsMICA/BULBP family proteinsNatural cytotoxicity receptor (NCR) ligandsNKp30 ligandsNKp44 ligandsNKp46 ligandsHLA class I molecules (downregulation/loss)Stress-induced antigens
02

Mechanism of action

Enhance ligand expression for activating receptors or block inhibitory pathways to boost anti-tumor activity mediated through the NK cell axis.

03

Biological functions

Immune responseCell deathTumor immunosurveillanceActivating NK cell cytotoxicityInhibiting NK cell cytotoxicity
04

Disease associations

CancerImmune evasion
05

Safety considerations

Potential for off-target effects on normal cells expressing activating ligandsRisk of cytokine release syndromeImmune-related adverse events
06

Biomarkers

MICA/B expressionULBP expressionHLA-I expression levels

Beyond the preview

Go deeper on Tumor Cell Membrane Antigen (via Natural Killer Cell Recognition).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tumor Cell Membrane Antigen (via Natural Killer Cell Recognition).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call